These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21122641)

  • 1. A case report of a diabetic woman with very low HDL cholesterol.
    Chaychi L; Kinlaw WB; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2010; 4(2):133-5. PubMed ID: 21122641
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein cholesterolaemia.
    Katabami T; Murakami M; Kobayashi S; Matsui T; Ujihara M; Takagi S; Higa M; Ichijo T; Ohta A; Tanaka Y
    J Int Med Res; 2014 Apr; 42(2):457-67. PubMed ID: 24595147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.
    Lupattelli G; Roscini AR; Siepi D; Mannarino E
    J Clin Pharm Ther; 2010 Oct; 35(5):613-5. PubMed ID: 20831686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rosuvastatin in achieving target HDL, LDL, triglycerides and total cholesterol levels in type 2 diabetes mellitus (T2DM) with newly diagnosed dyslipidaemia: an open label, nonrandomised, non-interventional and observational study in India.
    Shah SN; Arneja J
    J Assoc Physicians India; 2013 Oct; 61(10):721-6, 732. PubMed ID: 24772729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The work-up for mixed hyperlipidemia: a case study.
    Rehman HU
    J Fam Pract; 2012 Mar; 61(3):133-6. PubMed ID: 22393551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Bilz S
    Ther Umsch; 2017; 74(8):445-453. PubMed ID: 29461147
    [No Abstract]   [Full Text] [Related]  

  • 8. Surprises and reaffirmations in 2008 clinical trials.
    Mandell BF
    Cleve Clin J Med; 2009 Jan; 76(1):6. PubMed ID: 19122106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid management--treatment goal and strategy].
    Koshiyama H
    Nihon Rinsho; 2006 Nov; 64(11):2102-6. PubMed ID: 17087303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
    Pan J; Shilian P; Ishida B; Wu X; Kane JP; Malloy MJ; Charles MA
    Metabolism; 2011 Feb; 60(2):292-7. PubMed ID: 20303127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ; Lundman P; Tardif JC
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exaggerated benefits of rosuvastatin compared with other statins.
    Qizilbash N
    Pharmacoepidemiol Drug Saf; 2009 May; 18(5):425-6. PubMed ID: 19382149
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosuvastatin and diabetes: when the evidences talk.
    Barrios V; Escobar C
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):115-24. PubMed ID: 23094943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Med could reverse arterial blockages.
    Health News; 2006 Jul; 12(7):13. PubMed ID: 16858860
    [No Abstract]   [Full Text] [Related]  

  • 16. Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
    Rosenson RS; Carlson DM; Kelly MT; Setze CM; Hirshberg B; Stolzenbach JC; Williams LA
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):47-57. PubMed ID: 21174145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment for dyslipidemias in patients with arterial hypertension].
    Chazova IE; Kukharchuk VV; Ratova LG; Kaminnaia VI
    Ter Arkh; 2007; 79(4):53-7. PubMed ID: 17564020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
    Vergès B; Florentin E; Baillot-Rudoni S; Petit JM; Brindisi MC; Pais de Barros JP; Lagrost L; Gambert P; Duvillard L
    J Lipid Res; 2009 Jun; 50(6):1209-15. PubMed ID: 19168444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.